Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | MAPT | P10636 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | HPSE | Q9Y251 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.37 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.37 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.37 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.37 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.37 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.37 |
| ▸ | GSTP1 | P09211 | 1/20 | 0.35 |
| ▸ | ALPG | P10696 | 1/20 | 0.35 |
| ▸ | PTK2B | Q14289 | 1/20 | 0.35 |
| ▸ | RXRA | P19793 | 1/20 | 0.35 |
| ▸ | RXRB | P28702 | 1/20 | 0.35 |
| ▸ | RXRG | P48443 | 1/20 | 0.35 |
| ▸ | FAAH | O00519 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21110938 | 1.00 | TYR (0.53) | TYRLMNAMAPTL3MBTL1HPSE | |
| SCHEMBL10961600 | 0.88 | TYR (0.50) | TYRLMNAMAPTL3MBTL1 | |
| SCHEMBL2793857 | 0.88 | HPSE (0.45) | TYRLMNAMAPTL3MBTL1HPSE | |
| SCHEMBL2793853 | 0.88 | HPSE (0.45) | TYRLMNAMAPTL3MBTL1HPSE | |
| SCHEMBL25383688 | 0.88 | HPSE (0.45) | TYRLMNAMAPTL3MBTL1HPSE | |
| SCHEMBL25383684 | 0.88 | HPSE (0.45) | TYRLMNAMAPTL3MBTL1HPSE | |
| SCHEMBL6257581 | 0.88 | HPSE (0.45) | TYRLMNAMAPTL3MBTL1HPSE | |
| SCHEMBL13013400 | 0.88 | HPSE (0.45) | TYRLMNAMAPTL3MBTL1HPSE | |
| SCHEMBL4967981 | 0.87 | TYR (0.49) | TYRLMNAMAPTL3MBTL1HPSE | |
| SCHEMBL17068325 | 0.85 | HPSE (0.43) | TYRLMNAMAPTL3MBTL1HPSE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-119331136-A | Components of olefin polymerization catalyst, olefin polymerization catalyst and application thereof | 中国石油天然气股份有限公司 | 2025-01-21 | — | — | CN | claimed |
| EP-1066277-A1 | POLYETHOXYLATED ASCORBIC ACID DERIVATIVES AS A NOVEL ANTIOXIDANT AND PROCESS FOR PREPARING THEREOF | LG Chem Investment, Ltd (KR) | 2001-01-10 | — | — | EP | claimed |
| WO-1999050258-A1 | POLYETHOXYLATED ASCORBIC ACID DERIVATIVES AS A NOVEL ANTIOXIDANT AND PROCESS FOR PREPARING THEREOF | LG CHEMICAL LTD. (KR) | 1999-10-07 | — | — | WO | claimed |
| CN-119331136-A | Components of olefin polymerization catalyst, olefin polymerization catalyst and application thereof | 中国石油天然气股份有限公司 | 2025-01-21 | — | — | CN | disclosed |
| EP-3280402-B1 | TOLAN COMPOUNDS FOR PROMOTING WOUND HEALING | BIOMENDICS LLC (US) | 2024-06-05 | — | — | EP | disclosed |
| CN-107847466-B | Formulations and methods for modulating wound healing | 贝欧曼蒂克丝公司 | 2024-02-06 | — | — | CN | disclosed |
| US-11786481-B2 | Formulation and process for modulating wound healing | BioMendics, LLC (US) | 2023-10-17 | — | — | US | disclosed |
| CN-110218230-B | Vitamin C coupled platinum complex, intermediate thereof, preparation method thereof, pharmaceutical composition and application | 天津谷堆生物医药科技有限公司 | 2022-06-28 | — | — | CN | disclosed |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2021-07-29 | — | — | US | disclosed |
| US-10426742-B2 | Formulation and process for modulating wound healing | BioMendics, LLC (US) | 2019-10-01 | — | — | US | disclosed |
| US-20190022029-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2019-01-24 | — | — | US | disclosed |
| US-20160296477-A1 | Formulation and Process for Modulating Wound Healing | BioMendics, LLC (US) | 2016-10-13 | — | — | US | disclosed |
| US-20150250169-A1 | ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT | NIPPON SODA CO., LTD. (JP) | 2015-09-10 | — | — | US | disclosed |
| US-20150250169-A1 | ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT | NIPPON SODA CO., LTD. (JP) | 2015-09-10 | — | — | US | disclosed |
| EP-2902387-A1 | ASCORBIC ACID-RELATED COMPOUND AND ANTI-PLANT-VIRUS AGENT | Nippon Soda Co., Ltd. (JP) | 2015-08-05 | — | — | EP | disclosed |
| EP-1066277-B1 | POLYETHOXYLATED ASCORBIC ACID DERIVATIVES AS A NOVEL ANTIOXIDANT AND PROCESS FOR PREPARING THEREOF | LG CHEM INVESTMENT LTD (KR) | 2003-07-09 | — | — | EP | disclosed |
| US-6444144-B1 | FOOD, FEED, DRUGS AND COSMETICS | LG CHEMICAL LTD. (KR) | 2002-09-03 | — | — | US | disclosed |
| EP-1066277-A1 | POLYETHOXYLATED ASCORBIC ACID DERIVATIVES AS A NOVEL ANTIOXIDANT AND PROCESS FOR PREPARING THEREOF | LG Chem Investment, Ltd (KR) | 2001-01-10 | — | — | EP | disclosed |
| WO-1999050258-A1 | POLYETHOXYLATED ASCORBIC ACID DERIVATIVES AS A NOVEL ANTIOXIDANT AND PROCESS FOR PREPARING THEREOF | LG CHEMICAL LTD. (KR) | 1999-10-07 | — | — | WO | disclosed |
| US-4552888-A | Ascorbic acid ethers in angiogene | ELI LILLY AND COMPANY (US) | 1985-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150250169-A1 | ASCORBIC ACID-RELATED COMPOUND AND PLANT ANTIVIRAL AGENT | CBR3, OSR1, OXSR1 | TYR 3998/4885LMNA 4569/4885MAPT 4717/4885 |
| US-11786481-B2 | Formulation and process for modulating wound healing | SQSTM1, ATG7, TFEB | TYR 1758/4885LMNA 2060/4885MAPT 3534/4885 |
| US-20160296477-A1 | Formulation and Process for Modulating Wound Healing | SQSTM1, ATG7, TFEB | TYR 1857/4885LMNA 2142/4885MAPT 3766/4885 |
| US-20210228501-A1 | Formulation and Process for Modulating Wound Healing | ATG7, SQSTM1, ATF4 | TYR 956/4885LMNA 2342/4885MAPT 3091/4885 |
| US-10426742-B2 | Formulation and process for modulating wound healing | SQSTM1, ATG7, TFEB | TYR 1758/4885LMNA 2060/4885MAPT 3534/4885 |
| US-20190022029-A1 | Formulation and Process for Modulating Wound Healing | SQSTM1, ATG7, TFEB | TYR 1758/4885LMNA 2060/4885MAPT 3534/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.